GRI Bio shares are trading higher after the company announced three abstracts and an oral presentation highlighting data from the Phase 2a GRI-0621-IPF-02 study have been selected for presentation at ERS Congress 2026.

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings

8-K filing — GRI Bio, Inc. (GRI)

Filed: 2026-06-18 AccNo: 0001824293-26-000050 Size: 248 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

GRI Bio Says FDA Grants Orphan Drug Designation To GRI-0621 For Treatment Of Idiopathic Pulmonary Fibrosis, Irreversible And Ultimately Fatal Lung Disease